Literature DB >> 19251702

Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth.

Julia Sämann1, Jan Hegermann, Erika von Gromoff, Stefan Eimer, Ralf Baumeister, Enrico Schmidt.   

Abstract

Mutations in two genes encoding the putative kinases LRRK2 and PINK1 have been associated with inherited variants of Parkinson disease. The physiological role of both proteins is not known at present, but studies in model organisms have linked their mutants to distinct aspects of mitochondrial dysfunction, increased vulnerability to oxidative and endoplasmic reticulum stress, and intracellular protein sorting. Here, we show that a mutation in the Caenorhabditits elegans homologue of the PTEN-induced kinase pink-1 gene resulted in reduced mitochondrial cristae length and increased paraquat sensitivity of the nematode. Moreover, the mutants also displayed defects in axonal outgrowth of a pair of canal-associated neurons. We demonstrate that in the absence of lrk-1, the C. elegans homologue of human LRRK2, all phenotypic aspects of pink-1 loss-of-function mutants were suppressed. Conversely, the hypersensitivity of lrk-1 mutant animals to the endoplasmic reticulum stressor tunicamycin was reduced in a pink-1 mutant background. These results provide the first evidence of an antagonistic role of PINK-1 and LRK-1. Due to the similarity of the C. elegans proteins to human LRRK2 and PINK1, we suggest a common role of both factors in cellular functions including stress response and regulation of neurite outgrowth. This study might help to link pink-1/PINK1 and lrk-1/LRRK2 function to the pathological processes resulting from Parkinson disease-related mutants in both genes, the first manifestations of which are cytoskeletal defects in affected neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251702      PMCID: PMC2713553          DOI: 10.1074/jbc.M808255200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

Authors:  M Emdadul Haque; Kelly J Thomas; Cheryl D'Souza; Steve Callaghan; Tohru Kitada; Ruth S Slack; Paul Fraser; Mark R Cookson; Anurag Tandon; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-24       Impact factor: 11.205

2.  Axonal and neuronal amyloid precursor protein immunoreactivity in the brains of guinea pigs given tunicamycin.

Authors:  J W Finnie; J Manavis; P C Blumbergs; T R Kuchel
Journal:  Vet Pathol       Date:  2000-11       Impact factor: 2.221

3.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

4.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.

Authors:  Clement A Gautier; Tohru Kitada; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

5.  RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.

Authors:  K Häbig; M Walter; S Poths; O Riess; M Bonin
Journal:  Neurogenetics       Date:  2007-12-21       Impact factor: 2.660

6.  The kinase domain of mitochondrial PINK1 faces the cytoplasm.

Authors:  Chun Zhou; Yong Huang; Yufang Shao; Jessica May; Delphine Prou; Celine Perier; William Dauer; Eric A Schon; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

7.  Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.

Authors:  Sho Takatori; Genta Ito; Takeshi Iwatsubo
Journal:  Neurosci Lett       Date:  2007-11-26       Impact factor: 3.046

8.  LRRK2 regulates synaptic vesicle endocytosis.

Authors:  Narae Shin; Hyerhan Jeong; Jungsun Kwon; Hye Young Heo; Jung June Kwon; Hye Jin Yun; Cy-Hyun Kim; Baek Soo Han; Youren Tong; Jie Shen; Taku Hatano; Nobutaka Hattori; Kwang-Soo Kim; Sunghoe Chang; Wongi Seol
Journal:  Exp Cell Res       Date:  2008-03-05       Impact factor: 3.905

9.  LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.

Authors:  Mahaboobi Jaleel; R Jeremy Nichols; Maria Deak; David G Campbell; Frank Gillardon; Axel Knebel; Dario R Alessi
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

10.  PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.

Authors:  Julia W Pridgeon; James A Olzmann; Lih-Shen Chin; Lian Li
Journal:  PLoS Biol       Date:  2007-06-19       Impact factor: 8.029

View more
  83 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity.

Authors:  Hyongjong Koh; Jongkyeong Chung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

Review 3.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

Review 4.  Watching worms whither: modeling neurodegeneration in C. elegans.

Authors:  Benjamin Wolozin; Christopher Gabel; Andrew Ferree; Maria Guillily; Atsushi Ebata
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans.

Authors:  Tao Ke; Abel Santamaria; Joao B T Rocha; Alexey A Tinkov; Rongzhu Lu; Aaron B Bowman; Michael Aschner
Journal:  Neurotox Res       Date:  2020-07-29       Impact factor: 3.911

6.  Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism.

Authors:  Siyu Wu; Lili Lei; Yang Song; Mengting Liu; Shibo Lu; Dan Lou; Yonghong Shi; Zhibin Wang; Defu He
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

7.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

Review 8.  Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond.

Authors:  Cole M Haynes; Christopher J Fiorese; Yi-Fan Lin
Journal:  Trends Cell Biol       Date:  2013-03-13       Impact factor: 20.808

9.  Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways.

Authors:  Rosa M Sancho; Bernard M H Law; Kirsten Harvey
Journal:  Hum Mol Genet       Date:  2009-07-22       Impact factor: 6.150

10.  SnAvi--a new tandem tag for high-affinity protein-complex purification.

Authors:  Ursula Schäffer; Andreas Schlosser; Kristian M Müller; Angelika Schäfer; Nenad Katava; Ralf Baumeister; Ekkehard Schulze
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.